In8bio News

Promising Preclinical Data Underpins Buy Rating for IN8bio's NsCAR Platform

TipRanksApr 12 01:45 ET

IN8bio Analyst Ratings

BenzingaApr 10 10:49 ET

Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON) and IN8bio (INAB)

TipRanksApr 10 10:20 ET

Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)

TipRanksMar 19 02:21 ET

IN8bio Analyst Ratings

BenzingaMar 18 07:31 ET

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and IN8bio (INAB)

TipRanksMar 15 06:20 ET

IN8bio Analyst Ratings

BenzingaMar 15 06:08 ET

IN8bio Analyst Ratings

BenzingaMar 13 04:46 ET

Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)

TipRanksJan 9 01:50 ET

IN8bio Analyst Ratings

BenzingaNov 13, 2023 10:49 ET

Buy Rating Assigned to IN8bio: Promising Clinical Data and Favorable Q3 Financial Performance Propel Future Prospects

TipRanksNov 13, 2023 06:36 ET

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB) and Editas Medicine (EDIT)

TipRanksNov 8, 2023 01:50 ET

Analyst Maintains Buy Rating for IN8bio Based on Positive SITC Release and Promising R&D Developments

TipRanksSep 29, 2023 02:39 ET

HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

BenzingaAug 11, 2023 07:25 ET

IN8bio Analyst Ratings

BenzingaAug 11, 2023 07:16 ET

IN8bio (INAB) Gets a Buy From H.C. Wainwright

TipRanksAug 11, 2023 06:45 ET

Mizuho Securities Sticks to Their Buy Rating for IN8bio (INAB)

TipRanksAug 10, 2023 20:55 ET

Analysts Are Bullish on Top Healthcare Stocks: Oncolytics Biotech (ONCY), IN8bio (INAB)

TipRanksJun 5, 2023 10:20 ET

IN8bio (INAB) Gets a Buy From EF Hutton

TipRanksJun 5, 2023 04:25 ET

EF Hutton Reiterates Buy on IN8bio, Maintains $8 Price Target

BenzingaJun 5, 2023 04:10 ET